Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction have?
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction has 7,005 citations in the OpenAlex counts ScholarIQ stores.
When was Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction published?
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction has 2019 year in the ScholarIQ index.
What is the open-access status of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction?
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction has bronze oa status in the ScholarIQ index.
What is the DOI of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction?
The DOI for Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction is on the source record.
What is the PMID of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction?
The PMID for Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction is on the source record.
What is the OpenAlex record for Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction?
The OpenAlex for Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction is on the source record.